Molecular Underpinnings in the Establishment of an Oncogenic 3D Genome in Response to Environmental Arsenic Exposure

建立响应环境砷暴露的致癌 3D 基因组的分子基础

基本信息

项目摘要

Abstract Establishing the influence of pollutants on genome function is essential in defining their impact on human health. Environmental pollutants such as inorganic arsenic (iAs) are responsible for over thirteen million deaths yearly. Importantly, 24% of the diseases caused by environmental exposures might have been avoided by disease prevention, diagnosis and the development of safer metal-based therapeutic agents. In order to understand how these pollutants cause disease, we need to understand how pollutants change gene expression. Proper gene regulation is essential for normal growth, development and etiology of diseases such as cancer. Eukaryotic DNA stored as chromatin plays an integral role in gene regulation. At the one- dimensional (1D) level, chromatin is found as nucleosomes and at the three dimensional level (3D), chromatin is found in loops and topological domains, both of which regulate gene expression by allowing accessibility to the DNA wrapped up as chromatin. Inorganic arsenic is a ubiquitous metal that impacts gene regulation through modulating the epigenome. We recently provided the epigenetic landscape (DNA methylation, histone PTMs and histone variants) mediated by iAs. This landscape though important, makes it difficult to decipher whether the observed effects on gene activity are due to local changes in epigenetic environments, or effects caused by remote changes several kilobases away, such as the activity of enhancer(s). Additionally, the effect of the 3D chromatin structure supersedes that at the 1D chromatin level. This 3D information is mediated by CTCF, known as a ‘master weaver’ of the genome, and any dysregulation of the CTCF binding alters this 3D structure, resulting in gene dysregulation. We recently showed that iAs selectively inhibits CTCF from binding to some of its target sites and instigating oncogenic expression patterns. Interestingly, carcinogenesis is not a linear process but involves a several hybrid in-between stages till final cancer state. We therefore hypothesize that by inhibiting CTCF binding, iAs reorganizes the genome to maintain specific topologically-activated domains at the 3D chromatin structure to drive specific oncogenic potentials. To test this hypothesis, we will map CTCF binding (Aim 1), chromatin 3D (Aim 2) and ChIP-seq of histone marks (Aim 3) as cells undergo iAs- mediated carcinogenesis. The knowledge derived from the proposed studies will allow us to characterize the resulting gene regulatory network mediated by iAs exposure, and allow us to unambiguously anchor iAs exposure to changes in the CTCF interactome in the process of iAs-mediated cancer. Additionally, these studies will allow us to decipher how iAs initiates, establishes and maintains particular chromatin signatures that ultimately drive gene expression in iAs pathogenesis. Such studies are critically needed for the identification of translational targets and the development of therapeutic drugs needed in iAs-disease pathology.
抽象的 建立污染物对基因组功能的影响对于确定其对人的影响至关重要 健康。环境污染物(例如无机砷(IAS))造成1300万人死亡 每年。重要的是,可能已经避免了由环境暴露引起的24%的疾病 疾病预防,诊断和更安全的基于金属的治疗剂的发展。为了 了解这些污染物如何引起疾病,我们需要了解污染物如何改变基因 表达。适当的基因调节对于疾病的正常生长,发展和病因至关重要 作为癌症。以染色质为基因调节中持续的真核DNA在基因调节中起着不可或缺的作用。在一个 尺寸(1D)水平,染色质被发现为核小体,在三维水平(3D),染色质中 在循环和拓扑结构域中发现,这两者都可以通过可访问性来调节基因表达 DNA包裹为染色质。无机砷是一种无处不在的金属,影响基因调节 通过调节表观基因组。我们最近提供了表观遗传景观(DNA甲基化,组蛋白 PTMS和Hisstone变体)由IAS介导。这种景观虽然很重要,但很难破译 观察到的对基因活性的影响是由于表观遗传环境中局部变化引起的还是影响 由于远程变化而引起的几千碱基,例如增强剂的活性。另外,效果 在1D染色质水平上取代的3D染色质结构中。此3D信息由 CTCF,被称为基因组的“主编织者”,CTCF结合的任何失调都会改变这3D 结构,导致基因失调。我们最近表明,IAS选择性抑制CTCF的结合 到其一些目标位点和煽动致癌表达模式。有趣的是,癌变不是 线性过程,但涉及到最终癌症状态之间的一些混合阶段。因此,我们假设 通过抑制CTCF结合,IAS重新组织了基因组以维持特定的拓扑激活 3D染色质结构的结构域以驱动特定的致癌潜力。为了检验这一假设,我们将 MAP CTCF结合(AIM 1),染色质3D(AIM 2)和组蛋白标记的ChIP-seq(AIM 3)随着细胞经历IAS- 介导的致癌作用。从拟议的研究中得出的知识将使我们能够表征 由IAS暴露介导的基因调节网络,使我们能够明确锚定IAS 在IAS介导的癌症过程中,CTCF相互作用组的变化暴露。另外,这些 研究将使我们能够破译IAS的启动,建立和维护特定的染色质特征 最终驱动IAS发病机理中的基因表达。这样的研究至关重要 识别翻译靶标的和IAS酶中所需的热药的发展 病理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yvonne Nsokika Fondufe-Mittendorf其他文献

Yvonne Nsokika Fondufe-Mittendorf的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yvonne Nsokika Fondufe-Mittendorf', 18)}}的其他基金

Molecular Underpinnings in the Establishment of an Oncogenic 3D Genome inResponse to Environmental Arsenic Exposure
建立响应环境砷暴露的致癌 3D 基因组的分子基础
  • 批准号:
    10594774
  • 财政年份:
    2022
  • 资助金额:
    $ 49.15万
  • 项目类别:
Molecular mechanisms of iAs-mediated carcinogenesis through the lens of histone H2B variants
通过组蛋白 H2B 变异观察 iAs 介导的致癌作用的分子机制
  • 批准号:
    10616739
  • 财政年份:
    2022
  • 资助金额:
    $ 49.15万
  • 项目类别:
Molecular Underpinnings in the Establishment of an Oncogenic 3D Genome inResponse to Environmental Arsenic Exposure
建立响应环境砷暴露的致癌 3D 基因组的分子基础
  • 批准号:
    10610974
  • 财政年份:
    2022
  • 资助金额:
    $ 49.15万
  • 项目类别:
Diversity Supplement: The Role of Chromatin Structural and Epigenetic Changes in Arsenic-Induced Gene Expression Supplement
多样性补充:染色质结构和表观遗传变化在砷诱导的基因表达补充中的作用
  • 批准号:
    9278387
  • 财政年份:
    2016
  • 资助金额:
    $ 49.15万
  • 项目类别:
The role of chromatin structural and epigenetic changes in arsenic-induced gene expression
染色质结构和表观遗传变化在砷诱导的基因表达中的作用
  • 批准号:
    8887884
  • 财政年份:
    2015
  • 资助金额:
    $ 49.15万
  • 项目类别:
UNDERSTANDING THE MOLECULAR BASIS OF EPIGENETIC TRANSCRIPTIONAL SILENCING
了解表观遗传转录沉默的分子基础
  • 批准号:
    8360578
  • 财政年份:
    2011
  • 资助金额:
    $ 49.15万
  • 项目类别:

相似国自然基金

面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
  • 批准号:
    62302218
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
  • 批准号:
    82260745
  • 批准年份:
    2022
  • 资助金额:
    33.00 万元
  • 项目类别:
    地区科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
  • 批准号:
    32100438
  • 批准年份:
    2021
  • 资助金额:
    24.00 万元
  • 项目类别:
    青年科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Research Project 2
研究项目2
  • 批准号:
    10403256
  • 财政年份:
    2023
  • 资助金额:
    $ 49.15万
  • 项目类别:
Project 2: Impact of H1/H2 haplotypes on cellular disease-associated phenotypes driven by FTD-causing MAPT mutations
项目 2:H1/H2 单倍型对 FTD 引起的 MAPT 突变驱动的细胞疾病相关表型的影响
  • 批准号:
    10834336
  • 财政年份:
    2023
  • 资助金额:
    $ 49.15万
  • 项目类别:
Engineering 3D Osteosarcoma Models to Elucidate Biology and Inform Drug Discovery
工程 3D 骨肉瘤模型以阐明生物学并为药物发现提供信息
  • 批准号:
    10564801
  • 财政年份:
    2023
  • 资助金额:
    $ 49.15万
  • 项目类别:
Role of POU4F1 in a Novel Form of Ataxia
POU4F1 在新型共济失调中的作用
  • 批准号:
    10741382
  • 财政年份:
    2023
  • 资助金额:
    $ 49.15万
  • 项目类别:
Multi-modal profiling of spatially resolved cell types mediating opioid withdrawal
介导阿片类药物戒断的空间分辨细胞类型的多模式分析
  • 批准号:
    10787010
  • 财政年份:
    2023
  • 资助金额:
    $ 49.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了